並列タイトル等抗精神病薬投与中の高プロラクチン血症と凝固因子の関係
コウ セイシンビョウ ヤク トウヨ チュウ ノ コウ プロラクチン ケッショウ ト ギョウコ インシ ノ カンケイ
タイトル（掲載誌）Neuropsychiatric Disease and Treatment
一般注記type:Thesis
Objective: The strong association between psychiatric patients who receive antipsychotics and the incidence of venous thromboembolism (VTE) is known. Although previous reports suggest that hyperprolactinemia often increases markers of activated coagulation, few studies have examined the direct relationship between the prolactin level elevated by antipsychotics and activated markers of activated coagulation. Method: The participants included 182 patients with schizophrenia (male =89, female =93) who received antipsychotic treatments for at least 3 months. Markers of VTE (D-dimer, fibrin/fibrinogen degradation products, and thrombin–antithrombin complex) and serum prolactin concentrations were measured. Results: Prolactin levels were significantly correlated with the logarithmic transformation of the D-dimer (r=0.320, P=0.002) and fibrin/fibrinogen degradation product levels (r=0.236, P=0.026) but not of the thrombin–antithrombin complex level (r=0.117, ns) among men. However, no correlations were found between the VTE markers and prolactin levels among women. These results were confirmed using multiple regression analyses that included demographic factors and antipsychotic dosages. Conclusion: The current study indicates that hyperprolactinemia is associated with an increase in markers of activated coagulation among men receiving antipsychotics. This finding clinically implies that monitoring and modulating prolactin levels among men are important to decrease the risk of VTE.
掲載誌Neuropsychiatric Disease and Treatment, 11, 2015, p.477-484DOI http://dx.doi.org/10.2147/NDT.S75176
DOIinfo:doi/10.2147/NDT.S75176
コレクション（個別）国立国会図書館デジタルコレクション > デジタル化資料 > 博士論文
受理日（W3CDTF）2016-05-01T16:38:40+09:00
連携機関・データベース国立国会図書館 : 国立国会図書館デジタルコレクション